AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
South East Asia Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Influenza, HPV, Oncology, Gene Testing), End User - Forecast to 2031
... The Southeast Asia molecular diagnostics market is projected to reach USD 891.9 million by 2031 from an estimated USD 528.3 million in 2024, at a CAGR of 7.8% during the forecast period. Succeeding extensive secondary ... Read More
-
Cephalosporin Market Report by Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation), Route of Administration (Injection, Oral), Application (Respiratory Tract, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, and Others), and Region 2025-2033
... market is experiencing steady growth driven by increasing antibiotic-resistant infections, the demand for effective and safer treatment options, ongoing research and development efforts to introduce new cephalosporin formulations, and rising awareness among healthcare professionals regarding ... Read More
-
Sexually Transmitted Diseases (STDs) Drug
... Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2024-2030. HPV Drugs, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$74.3 Billion ... Read More
-
STD Testing
... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia Testing, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis ... Read More
-
Kaposi Sarcoma
... CAGR of 3.2% over the analysis period 2024-2030. HAART, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$101.5 Million by the end of the analysis period. ... Read More
-
Herpes Zoster Treatment
... at a CAGR of 1.9% over the analysis period 2024-2030. Antiviral Medications, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$134.0 Million by the end of ... Read More
-
Infectious Disease Diagnostics
... at a CAGR of 5.5% over the analysis period 2024-2030. Diagnostic Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the ... Read More
-
Anal Fistula Treatment
... at a CAGR of 4.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$207.5 Million While China is Forecast to Grow at 4.1% CAGR The Anal Fistula Treatment market in the U.S. ... Read More
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
Global Syphilis Rapid Test Kit Competitive Landscape Professional Research Report 2025
... causes syphilis. This kit typically contains all the necessary components for conducting a simple and quick test, including test cassettes, sample collection swabs or lancets, buffer solutions, and instructions for use. The test works by ... Read More
-
Sexually Transmitted Disease (STD) Diagnostics Market Report by Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, and Others), Device Type (Laboratory Devices, Point of Care (PoC) Devices), End User (Laboratory Testing, Point of Care (PoC) Testing), and Region 2025-2033
... Point of Care (PoC) Devices), End User (Laboratory Testing, Point of Care (PoC) Testing), and Region 2025-2033 The global sexually transmitted disease (STD) diagnostics market size reached USD 109.0 Billion in 2024. Looking forward, IMARC ... Read More
-
Syphilis Testing Market by Type (Primary and Secondary Syphilis, Latent and Tertiary Syphilis), Location of Testing (Laboratory Testing, Point-of-Care (POC) Testing), and Region 2025-2033
... 2024. Looking forward, IMARC Group expects the market to reach USD 2.0 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The growing prevalence of sexually transmitted diseases (STDs), the increasing incidences ... Read More
-
Global Syphilis Immunoassay Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Syphilis is a sexually transmitted disease caused by a bacterium called treponema pallidum. ... Read More
-
Global Syphilis Immunoassay Diagnostics Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Syphilis Immunoassay Diagnostics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Syphilis Diagnosis Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Syphilis is a chronic, systemic sexually transmitted disease caused by the leptospira. The global pharmaceutical ... Read More
-
Global Syphilis Diagnosis Market Growth (Status and Outlook) 2024-2030
... market, the Syphilis Diagnosis is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Syphilis Diagnosis ... Read More
-
Global Syphilis Testing Market Growth (Status and Outlook) 2024-2030
... market, the Syphilis Testing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Syphilis Testing ... Read More
-
Global Neurosyphilis Market Growth (Status and Outlook) 2024-2030
... Neurosyphilis is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Neurosyphilis market. Neurosyphilis are expected ... Read More
-
2024-2029 Kuwait Infectious Disease Testing Market - Virology, Bacteriology, Parasitology, Mycology - 2024 Supplier Shares, 2024-2029 Centralized and POC Volume and Sales Forecasts for 100 Respiratory, STD, Enteric, and other Microbiology Assays Performed in Hospitals, Commercial/Private Labs, POC Locations - Competitive Strategies and SWOT Analysis, Latest Technologies, Instrumentation Pipeline, Market Barriers and Risks
... Commercial/Private Labs, POC Locations - Competitive Strategies and SWOT Analysis, Latest Technologies, Instrumentation Pipeline, Market Barriers and Risks This unique report from LeadingMarketResearch.com provides information not available from any other source , including test volume ... Read More
-
Gene Therapy Market by Therapeutic Area (Cardiovascular Disorders, Dermatological Disorders, Genetic Disorders, Hematological Disorders, Metabolic Disorders, Muscle Disorders, Oncological Disorders, Ophthalmic Disorders and Other Disorders), Type of Vector (Adeno-associated Virus Vectors, Adenovirus Vectors, Herpes Simplex Virus Vectors, Lentivirus Vectors, Non-viral Vectors, Retrovirus Vectors and Other Viral Vectors), Type of Therapy (Gene Augmentation, Gene Editing, Gene Regulation, Oncolytic Immunotherapies and Other Therapies), Type of Gene Delivery Method (Ex Vivo Gene Delivery and In vivo Gene Delivery), Route of Administration (Intramuscular Route, Intratumoral Route, Intravenous Route, Subretinal Route and Other Routes of Administration), Geographical Regions (North America, Europe, Asia-Pacific, Latin America and Rest of the World), Leading Players and Sales Forecast: Industry Trends and Global Forecasts, Till 2035
... Virus Vectors, Lentivirus Vectors, Non-viral Vectors, Retrovirus Vectors and Other Viral Vectors), Type of Therapy (Gene Augmentation, Gene Editing, Gene Regulation, Oncolytic Immunotherapies and Other Therapies), Type of Gene Delivery Method (Ex Vivo Gene Delivery ... Read More
-
Global Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast to 2032
... of abuse testing market was valued at US$ 6,973 Million in 2023, and is predicted to reach US$ 11,715 Million by 2032. The use of illicit drugs is increasing across the globe. An estimated 296 ... Read More
-
Global Syphilis Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Syphilis is one of the vital sexually transmitted infections (STIs) caused by the bacteria named, ... Read More
-
UAE In-Vitro Diagnostics Market Assessment, By Product Type [Reagents and Consumables, Instruments, Data Management Software], By Technique [Immunodiagnostics, Molecular Diagnostics, Clinical Chemistry, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/Pharmacogenomics, HIV/AIDS, Gastroenterology, Ophthalmology, Others], By End-user, [Hospitals, Clinical Laboratories, Point-of-Care Testing Centers, Others], By Region, Opportunities and Forecast, 2017-2031F
... [Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/Pharmacogenomics, HIV/AIDS, Gastroenterology, Ophthalmology, Others], By End-user, [Hospitals, Clinical Laboratories, Point-of-Care Testing Centers, Others], By Region, Opportunities and Forecast, 2017-2031F UAE in-vitro diagnostics (IVD) market is ... Read More
-
Syphilis Immunoassay Diagnostics Market (Product: Analyzer and Kits & Reagents); Technology: (Chemiluminescence Assay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), Immunochromatographic Assay /Lateral Flow Assay, Treponema pallidum latex agglutination (TPLA) and Non-treponemal Flocculation Assay - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034 Syphilis Immunoassay Diagnostics Market - Scope of Report TMR's report on the global syphilis immunoassay diagnostics market studies the past as well as the current growth ... Read More
-
Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029
... market trends is crucial for healthcare providers, investors, and industry stakeholders. This report offers a detailed analysis of the factors driving growth, including the increasing recognition of infectious diseases as a global health concern. As ... Read More
Research Assistance
